0.9525
-0.0011 (-0.12%)
-0.0011 (-0.12%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ampio Pharmaceuticals Inc | AMPE | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.0011 | -0.12% | 0.9525 | 19:41:37 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 0.9414 | 0.9251 | 0.9998 | 0.99 | 0.9536 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,818 | 4,608,350 | $ 0.9537248 | $ 4,395,098 | 3,129,630 | 0.26 - 1.24 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:44:52 | 10 | $ 0.9525 | USD |
Ampio Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 168.16M | 176.54M | 174.01M | $ - | $ - | -0.14 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 15.86M | $ - | 0.00% | - | 1.60% |
Ampio Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AMPE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.71 | 1.00 | 0.70 | 0.868772 | 4,402,837 | 0.2425 | 34.15% |
| 1 Month | 0.74 | 1.00 | 0.6209 | 0.7904383 | 3,259,640 | 0.2125 | 28.72% |
| 3 Months | 0.57 | 1.24 | 0.56 | 0.8287724 | 3,445,457 | 0.3825 | 67.11% |
| 6 Months | 0.42 | 1.24 | 0.31 | 0.698461 | 2,893,473 | 0.5325 | 126.79% |
| 1 Year | 0.499 | 1.24 | 0.26 | 0.6673442 | 1,899,785 | 0.4535 | 90.88% |
| 3 Years | 0.58 | 4.9499 | 0.26 | 1.02 | 1,462,714 | 0.3725 | 64.22% |
| 5 Years | 3.00 | 4.9499 | 0.26 | 1.10 | 1,039,508 | -2.05 | -68.25% |
Ampio Pharmaceuticals Description
| Ampio Pharmaceuticals Inc is a biopharmaceutical company. The company focused primarily on developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process and decreasing vascular permeability. Ampio's leading product candidates are Ampion and Optina. It is currently conducting the second pivotal clinical trial in the United States for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee. |
